The Lenovo-backed edge computing technology producer has pulled in $30m through a round led by Elevate Ventures.
Month: December 2020
Osaro lifts series B round to $37m
The Comcast Ventures and iRobot Ventures-backed warehouse robotics software developer has added $21m to its latest round.
Cleo clasps $44m in series B round
SBI was among the participants in the financial management tool developer’s seriies B round, which will fund product development and US expansion.
Medirom seeks healthy returns in US IPO
The CCC Marketing-backed salon operator has set a range for an initial public offering set to net it between $16.8m and $19.2m.
Obio probes Tencent for series C-plus funding
Tencent invested $15.3m in gene therapy-focused research services provider Obio Technology in its third funding round of 2020.
Battleface charges to $12m series A
Greenlight Re-backed travel insurance startup Battleface has lured Drive Capital for a series A round set to drive its growth plans.
Line goes to $30m Access Ventures fund
Access Ventures’ second Asia-focused venture capital fund added Line Ventures and Manahusa Capital to an LP list already containing F&F and Nodo.
Parallel Domain packs in $11m series A
Toyota AI Ventures returned for a series A round that will be used to strengthen technology that helps create datasets for autonomous vehicle models.
WorkRamp brings home $17m
Omers Ventures led a series B round for the remote corporate coaching service, which had raised series A funding from investors including Slack last year.
Zego arrives at Drivit acquisition
EDP Ventures has exited telematics technology provider Drivit in a purchase by Zego, which will use its technology to verify insurance claims.
Airbnb aces IPO to raise $3.49bn
The Alphabet-backed accommodation marketplace priced its initial public offering well above its range in the second huge flotation this week, to secure a $47bn valuation.
MissFresh gets fed $306m
State-backed investors have provided late-stage funding for the online groceries delivery service, which is backed by Lenovo and Tencent.
Nuance Pharma notches up $181m series D
Konruns Pharma came on board as Nuance closed a round that will fund the clinical progress of its small molecule anti-tumour drug candidate.
Edgewise earns $95m in series C round
Novo returned to reinvest in the neuromuscular disorder therapy developer in a round that will fund the progress of its lead candidate through a phase 1 clinical trial.